ArticlePlastic and reconstructive surgery. Global open2026
Versatile Application of the Medial Femoral Condyle Free Flap: A 10-year Experience.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Management of osseous nonunion presents a significant challenge to reconstructive surgeons. Conventional treatment options include rigid internal fixation with nonvascularised bone graft, local pedicled vascularized bone flap, and microvascular free bone flaps. The medial femoral condyle free flap (MFC-FF) is versatile, with reliable blood supply, good pedicle length, and ability to be harvested in various compositions. It has been well described in the literature for scaphoid reconstruction following recalcitrant proximal pole nonunion. Its application in other areas of the body has not been so well reported. Methods: Data were retrospectively collected using the hospital clinical applications system for all patients undergoing MFC-FF under the senior authors between 2014 and 2024. Preoperative, intraoperative, and postoperative data were collected. Results: Ten cases are included (7 upper limb, 2 lower limb, and 1 head and neck). Indications included recalcitrant osseous avascular nonunion, infected nonunion, and cortical bone defect secondary to trauma/other pathology. Patient ages ranged from 17 to 61 years. Mean time from injury to surgery was 54 months. Postoperative follow-up ranged from 2 to 54 months (average 6 mo). All patients demonstrated improvement in pain, restoration of function, and evidence of osseous union on x-ray. No donor site complications were reported. Conclusions: We demonstrate the MFC-FF to be a versatile flap that can successfully reconstruct a variety of osteochondral defects across the body, in an otherwise challenging cohort. We report good functional outcomes and a high rate of union, with limited donor site morbidity. It is a reliable flap, with a short learning curve for successful flap raise.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.